AI assistant
NIKE, Inc. — Director's Dealing 2022
Oct 13, 2022
29865_dirs_2022-10-13_424776d3-dc9e-408f-9302-8c6f10f35b2b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: NIKE, Inc. (NKE)
CIK: 0000320187
Period of Report: 2022-10-07
Reporting Person: Nielsen Johanna (VP: CORP CONTROLLER)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Class B Common Stock | 3828.7888 | Direct |
| Class B Common Stock | 199 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Non-Qualified Stock Option (Right to Buy) | $82.20 | 2028-09-01 | Class B Common Stock (8215) | Direct | |
| Non-Qualified Stock Option (Right to Buy) | $84.50 | 2029-09-01 | Class B Common Stock (11835) | Direct | |
| Non-Qualified Stock Option (Right to Buy) | $114.84 | 2030-09-01 | Class B Common Stock (9280) | Direct | |
| Non-Qualified Stock Option (Right to Buy) | $164.56 | 2031-09-01 | Class B Common Stock (5900) | Direct | |
| Non-Qualified Stock Option (Right to Buy) | $106.49 | 2032-09-01 | Class B Common Stock (14260) | Direct |
Footnotes
F1: Includes shares acquired pursuant to NIKE, Inc.'s Employee Stock Purchase Plan.
F2: Shares held in account under the NIKE, Inc. 401(k) Savings and Profit Sharing Plan.
F3: Stock Option granted on 09/01/2018 and became exercisable with respect to 25% of the shares on each of the first four anniversaries of the date of the grant.
F4: Stock Option granted on 09/01/2019 and becomes exercisable with respect to 25% of the shares on each of the first four anniversaries of the date of the grant.
F5: Stock Option granted on 09/01/2020 and becomes exercisable with respect to 25% of the shares on each of the first four anniversaries of the date of the grant.
F6: Stock Option granted on 09/01/2021 and becomes exercisable with respect to 25% of the shares on each of the first four anniversaries of the date of the grant.
F7: Stock Option granted on 09/01/2022 and becomes exercisable with respect to 25% of the shares on each of the first four anniversaries of the date of the grant.